Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME. - Sun, Yi; Ren, Shangqing; Wen, Wei; Jing, Jun; Luo, Xu; Shao, Shuai; Duan, Ruiqi; Zeng, Guohua; Guo, Ju (Molecular Cancer, 2025)